QYR in News
Guobang Pharmaceutical Group Co., Ltd. Cites QYResearch Published Sodium Borohydride Market Report on October 11
According to QYResearch data, since 2022, sodium borohydride, the preferred reducing agent for SM1 synthesis of Pfizer’s oral COVID‑19 drug, has driven continuous growth in pharmaceutical‑end demand.
Source: Baidu‑Baijiahao Public Disclosure URL: https://baijiahao.baidu.com/s?id=1878751702366593833&wfr=spider&for=pc
Global Sodium Borohydride Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Published Date: 2026-01-04
Pages: 76
Report ld: 5557585
Price：USD 4250.00
(Single User License)
Global Sodium Borohydride Market Research Report 2026
Published Date: 2026-01-04
Pages: 127
Report ld: 5535166
Price：USD 2900.00
(Single User License)
Sodium Borohydride- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Published Date: 2026-01-04
Pages: 99
Report ld: 5495556
Price：USD 3950.00
(Single User License)
Global Sodium Borohydride Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: 2025-09-11
Pages: 147
Report ld: 5044453
Price：USD 4900.00
(Single User License)
Global Sodium Borohydride Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: 2025-03-28
Pages: 122
Report ld: 4676025
Price：USD 5900.00
(Single User License)
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.